Clipboard Health vs Uncommon Therapeutics

Side-by-side comparison of AI visibility scores, market position, and capabilities

Clipboard Health leads in AI visibility (83 vs 27)

Clipboard Health

LeaderHealthcare

General

Healthcare per-diem staffing marketplace with 90%+ shift-fill rate and $100M revenue; profitable since 2022 backed by Sequoia competing with Shiftkey and CareRev for nurse per-diem placement.

AI VisibilityBeta
Overall Score
A83
Category Rank
#54 of 1167
AI Consensus
63%
Trend
down
Per Platform
ChatGPT
83
Perplexity
74
Gemini
87

About

Clipboard Health is a healthcare staffing marketplace that connects per-diem nurses, CNAs, and allied health professionals with healthcare facilities (nursing homes, hospitals, urgent care centers) for shift work — achieving a 90%+ shift-fill reliability rate versus the 60% industry average for traditional staffing agencies, and maintaining profitability since 2022. A Y Combinator graduate, Clipboard Health reached $100 million in annual revenue within three years of founding, raised $94.1 million total led by Sequoia Capital, and serves tens of thousands of healthcare professionals across 1,000+ facilities.

Full profile

Uncommon Therapeutics

EmergingHealthcare

General

Rare disease biotech developing polytherapy approach for Rett Syndrome (1 in 10,000 girls); founder-developed protocol validated through personal patient experience competing with Acadia Pharmaceuticals Daybue in Rett market.

AI VisibilityBeta
Overall Score
D27
Category Rank
#1121 of 1167
AI Consensus
67%
Trend
stable
Per Platform
ChatGPT
28
Perplexity
33
Gemini
36

About

Uncommon Therapeutics is a biotech company founded by Noah Auerhahn — directly inspired by his daughter's diagnosis with Rett Syndrome, a severe genetic neurological disease affecting approximately 1 in 10,000 girls — applying a polytherapy approach (combining multiple therapeutic agents targeting different disease mechanisms simultaneously) to develop treatments for serious neurological and rare diseases. After improving his daughter's quality of life through a personally developed polytherapy protocol, Auerhahn founded Uncommon Therapeutics to translate these insights into pharmaceutical products for the broader Rett Syndrome patient community.

Full profile

AI Visibility Head-to-Head

83
Overall Score
27
#54
Category Rank
#1121
63
AI Consensus
67
down
Trend
stable
83
ChatGPT
28
74
Perplexity
33
87
Gemini
36
85
Claude
22
74
Grok
33

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.